Evidence map›Paper›PMID 30934651›Full record

ArticleMarine drugs2019

Spiralyde A, an Antikinetoplastid Dolabellane from the Brown Alga

Olfa Chiboub, Ines Sifaoui, Jacob Lorenzo-Morales, Manef Abderrabba, Mondher Mejri, José Javier Fernández, José E Piñero, Ana R Díaz-Marrero

Abstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Meroterpenoids fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
  3. The Biodiversity of the GenusMolecules (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. In Vitro Activity of Statins againstPathogens (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olfa ChiboubInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de La Laguna (ULL), Avda. Astrofísico F. Sánchez, 2, 38206 La Laguna, Tenerife, Spain. alu0101168852@ull.edu.es.
Ines SifaouiInstituto Universitario de Enfermedades Tropicales y Salud Pública de Islas Canarias, Universidad de La Laguna, Avda. Astrofísico F. Sánchez s/n, 38206 La Laguna, Tenerife, Spain. isifaoui@ull.edu.es.
Jacob Lorenzo-MoralesInstituto Universitario de Enfermedades Tropicales y Salud Pública de Islas Canarias, Universidad de La Laguna, Avda. Astrofísico F. Sánchez s/n, 38206 La Laguna, Tenerife, Spain. jmlorenz@ull.edu.es.
Manef AbderrabbaLaboratoire Matériaux-Molécules et Applications, IPEST, B.P 51, La Marsa, University of Carthage, Tunis 2070, Tunisia. manef.abderrabba@ipest.rnu.tn.
Mondher MejriLaboratoire Matériaux-Molécules et Applications, IPEST, B.P 51, La Marsa, University of Carthage, Tunis 2070, Tunisia. mondhermejri54@gmail.com.ORCID 0000-0002-4028-7910
José Javier FernándezInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de La Laguna (ULL), Avda. Astrofísico F. Sánchez, 2, 38206 La Laguna, Tenerife, Spain. jjfercas@ull.edu.es.ORCID 0000-0002-0805-8317
José E PiñeroInstituto Universitario de Enfermedades Tropicales y Salud Pública de Islas Canarias, Universidad de La Laguna, Avda. Astrofísico F. Sánchez s/n, 38206 La Laguna, Tenerife, Spain. jpinero@ull.edu.es.
Ana R Díaz-MarreroInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de La Laguna (ULL), Avda. Astrofísico F. Sánchez, 2, 38206 La Laguna, Tenerife, Spain. adiazmar@ull.edu.es.ORCID 0000-0002-8886-7519

Funding

Instituto de Salud Carlos III PI18/01380Interreg INTERREG-MAC/1.1b/042 (BIOTRANSFER2)Ministerio de Economía y Competitividad CTQ2014-55888-C03-01/RRedes Temáticas de Investigación Cooperativa, FIS RD16/0027/0001
6 · The paper itself

Abstract

Bioassay-guided fractionation of the antikinetoplastid extract of the brown alga

Indexed as

Chemical FractionationDiterpenesLeishmaniaMagnetic Resonance SpectroscopyPhaeophyceaeTrypanosoma cruziDiterpenesdolabellaneantikinetoplastidbrown algaeDictyota spiralisdolabellanesLeishmaniaSpiralyde ATrypanosoma

Identifiers

PMID30934651
PMCPMC6471066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.